These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 19566110

  • 1. Caspofungin: in pediatric patients with fungal infections.
    Garnock-Jones KP, Keam SJ.
    Paediatr Drugs; 2009; 11(4):259-69. PubMed ID: 19566110
    [Abstract] [Full Text] [Related]

  • 2. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD, Lyseng-Williamson KA, Scott LJ.
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [Abstract] [Full Text] [Related]

  • 3. Echinocandin antifungal drugs in fungal infections: a comparison.
    Chen SC, Slavin MA, Sorrell TC.
    Drugs; 2011 Jan 01; 71(1):11-41. PubMed ID: 21175238
    [Abstract] [Full Text] [Related]

  • 4. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
    Keating G, Figgitt D.
    Drugs; 2003 Jan 01; 63(20):2235-63. PubMed ID: 14498760
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.
    N Engl J Med; 2004 Sep 30; 351(14):1391-402. PubMed ID: 15459300
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Caspofungin: first approved agent in a new class of antifungals.
    Johnson MD, Perfect JR.
    Expert Opin Pharmacother; 2003 May 30; 4(5):807-23. PubMed ID: 12740003
    [Abstract] [Full Text] [Related]

  • 12. Caspofungin acetate for treatment of invasive fungal infections.
    Pacetti SA, Gelone SP.
    Ann Pharmacother; 2003 Jan 30; 37(1):90-8. PubMed ID: 12503942
    [Abstract] [Full Text] [Related]

  • 13. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA, Scott LJ.
    Drugs; 2008 Jan 30; 68(15):2225-55. PubMed ID: 18840009
    [Abstract] [Full Text] [Related]

  • 14. Echinocandins in the management of invasive fungal infections, Part 2.
    Morris MI, Villmann M.
    Am J Health Syst Pharm; 2006 Oct 01; 63(19):1813-20. PubMed ID: 16990627
    [Abstract] [Full Text] [Related]

  • 15. Caspofungin therapy in immunocompromised children and neonates.
    Somer A, Törün SH, Salman N.
    Expert Rev Anti Infect Ther; 2011 Mar 01; 9(3):347-55. PubMed ID: 21417874
    [Abstract] [Full Text] [Related]

  • 16. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB, Rathi SA, Ratho N, Subramanian R.
    J Assoc Physicians India; 2006 Dec 01; 54():943-8. PubMed ID: 17334012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.